ELAB
Elevai Labs, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.17M
P/E Ratio
—
EPS
$-382.61
Beta
0.71
52W High
$267.12
52W Low
$1.62
50-Day MA
$4.53
200-Day MA
$83.05
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Elevai Labs, Inc. Common Stock
Elevai Labs, Inc. (Ticker: ELAB) is a cutting-edge technology company focused on revolutionizing artificial intelligence and machine learning applications. With its advanced data analytics platforms, Elevai Labs facilitates enhanced decision-making across key sectors, particularly in healthcare and finance, enabling organizations to extract actionable insights from complex datasets. Positioned at the forefront of the rapidly evolving tech landscape, the company is well-equipped to capitalize on emerging trends, thereby delivering significant value and operational efficiency to its clients and stakeholders.
Fundamentals
| Revenue (TTM) | 590,080 |
| Gross Profit (TTM) | $-1.03M |
| EBITDA | $-7.03M |
| Operating Margin | -945.00% |
| Return on Equity | -107.30% |
| Return on Assets | -40.70% |
| Revenue/Share (TTM) | $28.99 |
| Book Value | $97.11 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | 18.93 |
| EV/Revenue | 13.29 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -45.80% |
| Shares Outstanding | $4.45M |
| Float | $1.16M |
| % Insiders | 0.06% |
| % Institutions | 0.05% |
More HEALTHCARE Stocks
Data last updated: 5/2/2026